FOCUS ON INNOVATIVE & DIFFICULT TO DEVELOP PRODUCTS

Zenvision filed around 28 Patents/PCTs.

Being a distinguished CRO with separate vertical extensively focusing on developing truly Novel or 505(b)(2) formulations. We we have filed around 28 Patent applications and 8 PCTs out of which 3 PCTs have been published with positive reviews.

•Zenvision has developed Platform Technologies to extend the Product Life Cycle for certain products which are going off patent

•Zenvision has Unique formulations for unmet medical needs

•Capability and Knowledge base for handing products in Cytotoxic, Anti-neoplastic, Inhalers and Hormones apart for regular products

•Zenvision has developed products which are potential candidates for 505b2